Nuvasive Announces Conference Call And Webcast Of Third Quarter 2017 Results

SAN DIEGO, Oct. 5, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will release its third quarter 2017 earnings results on Tuesday, October 24, 2017 after the close of the market.

NuVasive will hold a conference call on Tuesday, October 24, 2017 at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the third quarter 2017. The dial-in numbers are 1-877-407-9039 for domestic callers and 1-201-689-8470 for international callers. A live webcast of the conference call will be available online from the Investor Relations page of the Company's website at www.nuvasive.com.

After the live webcast, the call will remain available on NuVasive's website through November 21, 2017. In addition, a telephone replay of the call will be available until October 31, 2017. The replay dial-in numbers are 1-844-512-2921 for domestic callers and 1-412-317-6671 for international callers. Please use pin number: 13671687.

About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With $962 million in revenues (2016), NuVasive has an approximate 2,300 person workforce in more than 40 countries serving surgeons, hospitals and patients. For more information, please visit www.nuvasive.com.

Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. Thepotential risks and uncertainties which contribute to the uncertain nature of these statements include, but are not limited to, the risk that NuVasive's revenue or earnings projections may turn out to be inaccurate because of the preliminary nature of the forecasts; the risk of further adjustment to financial results or future financial expectations; unanticipated difficulty in selling products, generating revenue or producing expected profitability; and those other risks and uncertainties more fully described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

 

SOURCE NuVasive, Inc.

These press releases may also interest you at 14:05 Synedgen Completes IND-Enabling Studies for Two Parallel Programs for Lead Asset MIIST305 Synedgen, Inc., a biotechnology company targeting human glycobiology to treat gastrointestinal diseases, today announced it has completed IND-enabling studies for its lead candidate, MIIST305. MIIST305 is being developed for two parallel programs, an... at 14:00 PANTHERx® Rare Continues Explosive Growth with Expansions of Pharmacy, HQ and Distribution Locations PANTHERx®?Rare, the leader in rare disease pharmacy, patient access, and support services in?the United States, is pleased to announce three new expansions that will facilitate the company's continued growth and enhance its innovative capabilities to... at 13:55 Unveiling NyquistIQ: Your AI-Powered Research Assistant in Extracting Insights from the Data Deluge Data is everywhere, but insight is rare. Insights are hidden deep in the data and require tons of work and time to dig out. Knowledge professionals in clinical trials, medical, strategy, and regulatory affairs are struggling with the rapid growth of... at 13:54 INOVAIT awards two leading companies and one academic partner for transforming Canada's healthcare ecosystem INOVAIT, the national network for commercializing breakthroughs in image-guided therapy (IGT) and artificial intelligence, presented the inaugural INOVAIT awards at its annual Discovery Forum last week (April 18, 2024). The awards were established to... at 13:53 New NICO Myriad SPECTRAtm System Launching at Annual Neurosurgeon Meeting in Chicago Medical device innovator and worldwide leader in minimally invasive neurosurgery NICO Corporation is launching its latest product innovation at next week's American Association of Neurosurgical Surgeons (AANS) Annual Scientific Meeting in Chicago,... at 13:50 Rise in Healthcare Expenditure Boosting the Investment of the US Medical Bathtubs Market - More than $79.18 Million Market Opportunities - Exclusive Focus Insight Report by Arizton According to Arizton's latest focus research report, the US medical bathtubs market is growing at a CAGR of 2.27% during 2023-2029.... More news about Health...

News published on 5 october 2017 at 16:05 and distributed by: